Zealand Pharma is a Danish biotechnology company based in Copenhagen that discovers and develops peptide-based medicines. Its work centres on metabolic and gastrointestinal diseases, and it has developed treatments for severe low blood sugar and for rare conditions affecting the gut. The company also has partnerships with larger pharmaceutical firms to develop and commercialise its drug candidates. Its customers are mainly healthcare providers and patients through partners who market the finished medicines.
Zealand Pharma A/S trades under the code 0NZU on the London Stock Exchange in UK, with its price quoted in Danish kroner (DKK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3379 of 3788 on the London Stock Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
11/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-28.1%
From 52-week high-57.2%
MomentumWeak
11/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-25.0%
6-month return-25.4%
Stability (higher is calmer)Weak
14/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)72.0%
Worst drawdown, 1 year (smaller is calmer)-57.7%
LiquidityStrong
71/100
Trades actively.
See the numbers →
Avg daily value traded7.20M DKK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 221.70 – 531.60Daily closes, split-adjusted
Signals
50-day average273.44
200-day average311.95
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)45.25
Technical summary
Daily
Strongly bearish
2 bullish · 2 neutral · 11 bearish
Weekly
Strongly bearish
1 bullish · 0 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
227.2
Bearish
EMA 10
229.5
Bearish
SMA 20
238.5
Bearish
EMA 20
239.3
Bearish
SMA 50
273.4
Bearish
EMA 50
262.8
Bearish
SMA 100
286.8
Bearish
EMA 100
284.0
Bearish
SMA 200
311.9
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
30.35
Neutral
MACD (12, 26)
-13.94
Bearish
Momentum (12)
-6.52
Bearish
Stochastic %K (14)
2.69
Bullish
Williams %R (14)
-97.31
Bullish
CCI (20)
24.61
Neutral
Pivot points (classic, last session)
S3
103.7
S2
163.9
S1
194.1
Pivot
254.3
R1
284.5
R2
344.7
R3
374.9
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in DKK. Educational only, not financial advice.
